Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-၀.၂၁%
၁,၀၉၁.၅၁
-၂.၃၀
-၀.၂၁%
—၁,၀၉၃.၈၁၁,၀၉၆.၅၂၁,၁၀၀.၂၂၁,၀၉၁.၅၁——
SIXC
Communications
SIXC
Communications
SIXC
+၀.၂၂%
၆၁၀.၁၁
+၁.၃၄
+၀.၂၂%
—၆၀၈.၇၇၆၀၈.၇၇၆၁၂.၉၇၆၀၈.၇၇——
SIXE
Energy
SIXE
Energy
SIXE
-၁.၃၄%
၁,၂၃၇.၉၈
-၁၆.၈၃
-၁.၃၄%
—၁,၂၅၄.၈၁၁,၂၅၃.၀၁၁,၂၅၃.၈၇၁,၂၂၆.၃၃——
SIXI
Industrials
SIXI
Industrials
SIXI
-၀.၉၃%
၁,၇၄၄.၇၁
-၁၆.၄၀
-၀.၉၃%
—၁,၇၆၁.၁၁၁,၇၆၄.၂၇၁,၇၆၆.၈၈၁,၇၄၄.၇၁——
SIXM
Financials
SIXM
Financials
SIXM
-၀.၃၇%
၆၄၀.၁၈
-၂.၄၀
-၀.၃၇%
—၆၄၂.၅၈၆၄၄.၈၇၆၄၈.၄၈၆၄၀.၁၈——
SIXR
Staples
SIXR
Staples
SIXR
-၀.၁၈%
၈၄၉.၅၈
-၁.၅၅
-၀.၁၈%
—၈၅၁.၁၃၈၅၅.၆၆၈၅၈.၇၅၈၄၅.၅၆——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-၀.၂၃%
၂၁၇.၄၈
-၀.၅၀
-၀.၂၃%
—၂၁၇.၉၈၂၁၇.၉၈၂၁၈.၆၅၂၁၆.၈၈——
SIXT
Technology
SIXT
Technology
SIXT
+၁.၅၂%
၃,၂၆၀.၆၉
+၄၈.၈၆
+၁.၅၂%
—၃,၂၁၁.၈၃၃,၂၂၇.၂၁၃,၂၆၈.၃၈၃,၂၂၆.၅၅——
SIXU
Utilities
SIXU
Utilities
SIXU
-၀.၆၉%
၉၄၂.၄၅
-၆.၅၃
-၀.၆၉%
—၉၄၈.၉၈၉၄၈.၅၈၉၅၇.၈၃၉၄၁.၉၇——
SIXV
Health care
SIXV
Health care
SIXV
-၀.၅၂%
၁,၄၆၆.၈၀
-၇.၇၂
-၀.၅၂%
—၁,၄၇၄.၅၂၁,၄၇၉.၀၃၁,၄၈၁.၀၄၁,၄၆၆.၈၀——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+၀.၂၂%
၂,၃၉၇.၅၀
+၅.၃၈
+၀.၂၂%
—၂,၃၉၂.၁၂၂,၃၉၆.၉၅၂,၄၂၁.၂၂၂,၃၈၂.၃၂——
KALV:NASDAQ
Kalvista Pharmaceuticals Inc
၂၆.၆၅ US$
-၀.၀၄%
(-၀.၀၁၀) 1D
၂၆.၅၈ US$
-၀.၂၆% (-၀.၀၇၀)
After hours
Closed: မေ ၁, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KALV...
Open
၂၆.၆၆ US$
High
၂၆.၆၉ US$
Low
၂၆.၆၄ US$
Mkt. cap
၁၄၁.၆၉ ဋေ
Avg. vol.
၁.၁၉ သန်း
Volume
၅.၁၂ သန်း
52-wk high
၂၆.၆၉ US$
52-wk low
၉.၈၃ US$
Beta
-၀.၄၀
Shares outstanding
၅.၁၂ ကုဋေ
No. of employees
၂၇၅
News stories
From sources across the web
Stock Traders Daily
Stock Traders Daily
·
ပြီးခဲ့သည့် ၁၂ နာရီ
Avoiding Lag: Real-Time Signals in (KALV) Movement
Business Wire
Business Wire
·
ပြီးခဲ့သည့် ၁ ရက်
KalVista Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of KalVista Pharmaceuticals, Inc. - KALV
Stock Titan
Stock Titan
·
ပြီးခဲ့သည့် ၂ ရက်
KalVista (NASDAQ: KALV) amends 10-KT, reveals April 29, 2026 merger deal with Chiesi
The Globe and Mail
The Globe and Mail
·
ပြီးခဲ့သည့် ၃ ရက်
Chiesi to Acquire KalVista Pharmaceuticals in Cash Merger
About Kalvista Pharmaceuticals Inc
CEO-
Employees၂၇၅
Founded၂၀၀၄
HeadquartersFramingham, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitekalvista.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၄ အောက်
၂၀၂၅ ဇူ
၂၀၂၅ စက်
၂၀၂၅ ဒီ
Revenue
-
၁.၄၃ သန်း
၁.၃၇ ကုဋေ
၅.၉၉ ကုဋေ
Cost of goods sold
၁.၆၆ ကုဋေ
၁.၅၈ ကုဋေ
၁.၃၂ ကုဋေ
၁.၂၂ ကုဋေ
Cost of revenue
၁.၆၆ ကုဋေ
၁.၅၈ ကုဋေ
၁.၃၂ ကုဋေ
၁.၂၂ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂.၉၂ ကုဋေ
၄.၄၇ ကုဋေ
၃.၀၃ ကုဋေ
၆.၀၄ ကုဋေ
Operating expense
၂.၉၂ ကုဋေ
၄.၄၇ ကုဋေ
၃.၀၃ ကုဋေ
၆.၀၄ ကုဋေ
Total operating expenses
၄.၅၈ ကုဋေ
၆.၀၄ ကုဋေ
၅.၉၇ ကုဋေ
၇.၂၆ ကုဋေ
Operating income
-၄.၅၈ ကုဋေ
-၅.၉၀ ကုဋေ
-၄.၆၀ ကုဋေ
-၁.၂၇ ကုဋေ
Other non operating income
၁.၄၇ သန်း
၂.၃၁ သိန်း
၁.၇၂ သန်း
-၃.၅၁ သိန်း
EBT including unusual items
-၄.၂၃ ကုဋေ
-၅.၇၉ ကုဋေ
-၄.၄၃ ကုဋေ
-၁.၂၅ ကုဋေ
EBT excluding unusual items
-၄.၂၉ ကုဋေ
-၅.၈၅ ကုဋေ
-၄.၈၁ ကုဋေ
-၁.၂၀ ကုဋေ
Income tax expense
-
၂.၁၆ သန်း
၂.၁၆ သန်း
-၇.၁၀ သန်း
Effective tax rate
-
-၃.၇၂%
-၄.၅၆%
၁.၆၁%
Other operating expenses
-
-
-
-
Net income
-၄.၂၃ ကုဋေ
-၆.၀၁ ကုဋေ
-၄.၉၅ ကုဋေ
-၅.၃၇ သန်း
Net profit margin
-
-၄,၂၁၄.၃၁%
-၃၆၁.၃၉%
-၈.၉၆%
Earnings per share
-၀.၉၁
-၁.၁၂
-၀.၉၂
၀.၉၄
Interest and investment income
၁.၃၆ သန်း
၁.၈၅ သန်း
၁.၈၈ သန်း
၃.၃၇ သန်း
Interest expense
-
-၃.၅၂ သန်း
-၄.၇၆ သန်း
-၂.၉၄ သန်း
Net interest expenses
၁.၃၆ သန်း
-၁.၆၇ သန်း
-၁.၄၅ သန်း
-၅.၂၈ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၄.၅၆ ကုဋေ
-၅.၈၈ ကုဋေ
-၄.၅၈ ကုဋေ
-၁.၂၁ ကုဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer